Cargando…
P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430313/ http://dx.doi.org/10.1097/01.HS9.0000846616.21003.5d |
| _version_ | 1784779727860400128 |
|---|---|
| author | Raab, M. S. Cohen, Y. C. Schjesvold, F. Aardalen, K. Oka, A. Spencer, A. Wermke, M. Hari, P. Kaufman, J. L. Cafro, A. M. Ocio, E. M. Doki, N. Henson, K. Trabucco, G. Juif, P.-E. Chawla, R. Cotton, J. Fessehatsion, A. Fan, L. Blankenship, J. Granda, B. Lu, H. De Vita, S. |
| author_facet | Raab, M. S. Cohen, Y. C. Schjesvold, F. Aardalen, K. Oka, A. Spencer, A. Wermke, M. Hari, P. Kaufman, J. L. Cafro, A. M. Ocio, E. M. Doki, N. Henson, K. Trabucco, G. Juif, P.-E. Chawla, R. Cotton, J. Fessehatsion, A. Fan, L. Blankenship, J. Granda, B. Lu, H. De Vita, S. |
| author_sort | Raab, M. S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430313 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94303132022-08-31 P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA Raab, M. S. Cohen, Y. C. Schjesvold, F. Aardalen, K. Oka, A. Spencer, A. Wermke, M. Hari, P. Kaufman, J. L. Cafro, A. M. Ocio, E. M. Doki, N. Henson, K. Trabucco, G. Juif, P.-E. Chawla, R. Cotton, J. Fessehatsion, A. Fan, L. Blankenship, J. Granda, B. Lu, H. De Vita, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430313/ http://dx.doi.org/10.1097/01.HS9.0000846616.21003.5d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Raab, M. S. Cohen, Y. C. Schjesvold, F. Aardalen, K. Oka, A. Spencer, A. Wermke, M. Hari, P. Kaufman, J. L. Cafro, A. M. Ocio, E. M. Doki, N. Henson, K. Trabucco, G. Juif, P.-E. Chawla, R. Cotton, J. Fessehatsion, A. Fan, L. Blankenship, J. Granda, B. Lu, H. De Vita, S. P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA |
| title | P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA |
| title_full | P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA |
| title_fullStr | P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA |
| title_full_unstemmed | P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA |
| title_short | P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA |
| title_sort | p937: preclinical discovery and early findings from the phase 1, dose-escalation study of wvt078, a bcma-cd3 bispecific antibody, in patients with r/r multiple myeloma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430313/ http://dx.doi.org/10.1097/01.HS9.0000846616.21003.5d |
| work_keys_str_mv | AT raabms p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT cohenyc p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT schjesvoldf p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT aardalenk p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT okaa p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT spencera p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT wermkem p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT harip p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT kaufmanjl p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT cafroam p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT ocioem p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT dokin p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT hensonk p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT trabuccog p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT juifpe p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT chawlar p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT cottonj p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT fessehatsiona p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT fanl p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT blankenshipj p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT grandab p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT luh p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma AT devitas p937preclinicaldiscoveryandearlyfindingsfromthephase1doseescalationstudyofwvt078abcmacd3bispecificantibodyinpatientswithrrmultiplemyeloma |